Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Pharma 4.0 Focus Data Integrity by Design - Newer Approaches and Technologies to Cost Effective 21 CFR Part 11 Compliance (Aug 19, 2025)" training has ...
Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” but because its scope fundamentally changes how organizations must recruit, ...
Life sciences industry has regulatory compliance at the center of all its operations, so maintaining the integrity of data has always been a pressing need for this industry globally. Regulators such ...
Built-in data integrity is a bare minimum requirement in today’s BioPharmaceutical manufacturing. Good Manufacturing Practices (GMP) regulations of the Food and Drug Administration (FDA) highlight the ...
Dublin, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The "Computerized Systems Validation, Data Integrity & Cloud Computing In Pharma & Biotech (Dec 9th - Dec 10th, 2025)" training has been added to ...
The present world of digital transformation, streamlining workflows, enhancing operational efficiencies, and eliminating paper demands connected workflows with fully integrated systems and equipment.
CRM systems must evolve into intelligent networks integrating data, AI, and governance for effective orchestration in pharma. Unified data, embedded AI, and strategic governance form the foundation ...
A survey conducted by ICON has found sentiment towards artificial intelligence (AI) and digital tools in the clinical research sector is positive, with 49% of pharmaceutical and biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback